Showing 1 - 5 results of 5 for search 'G. DAgostino', query time: 0.03s Refine Results
  1. 1
    Multi-omics approach reveals promising salivary protein markers for head and neck squamous cell carcinoma prognosis

    Multi-omics approach reveals promising salivary protein markers for head and neck squamous cell carcinoma prognosis by Oriana Barros, Vito G. D'Agostino, Lucio Santos, Rita Ferreira, Rui Vitorino

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Identification of a potential prognostic panel of biomarkers for stratification of head and neck squamous cell carcinoma based on HPV status and TP53 mutational status

    Identification of a potential prognostic panel of biomarkers for stratification of head and neck squamous cell carcinoma based on HPV status and TP53 mutational status by Oriana Barros, Rita Ferreira, Vito G. D'Agostino, Francisco Amado, Lucio Santos, Rui Vitorino

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism

    Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism by L. Di Cesare Mannelli, G. D'Agostino, A. Pacini, R. Russo, M. Zanardelli, C. Ghelardini, A. Calignano

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Using network analysis to explore the association between eating disorders symptoms and aggressiveness in Bulimia nervosa

    Using network analysis to explore the association between eating disorders symptoms and aggressiveness in Bulimia nervosa by R. Ceres, M. Battipaglia, N. Attianese, S. Donato, R. Cerra, G. D’Agostino, A. M. Monteleone, P. Monteleone, G. Cascino

    Published 2024-04-01
    Get full text
    Article
  5. 5
    S111: REPEATED INFUSIONS OF ESCALATING DOSES OF EXPANDED AND ACTIVATED AUTOLOGOUS NATURAL KILLER CELLS IN MINIMAL RESIDUAL DISEASE-POSITIVE PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS. A GIMEMA PHASE 1 TRIAL

    S111: REPEATED INFUSIONS OF ESCALATING DOSES OF EXPANDED AND ACTIVATED AUTOLOGOUS NATURAL KILLER CELLS IN MINIMAL RESIDUAL DISEASE-POSITIVE PH+ ACUTE LYMPHOBLASTIC LEUKEMIA PATIENT... by G. F. Torelli, S. Chiaretti, N. Peragine, W. Barberi, L. Santodonato, G. D’Agostino, E. Abruzzese, M. I. Del Principe, A. Mancino, M. Matarazzo, M. S. Bafti, M Mancini, M. Messina, L. Castiello, A. Guarini, R. Foà

    Published 2022-06-01
    Get full text
    Article

Search Tools: